| CCERX | VITSX | CCERX / VITSX | |
| Total Expense Ratio | 1.08 | 0.03 | 3,600% |
| Annual Report Gross Expense Ratio | 1.46 | 0.03 | 4,867% |
| Fund Existence | 20 years | 29 years | - |
| Gain YTD | 0.176 | 1.378 | 13% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 453M | 2.06T | 0% |
| Annual Yield % from dividends | 0.45 | 1.10 | 41% |
| Returns for 1 year | 2.39 | 14.80 | 16% |
| Returns for 3 years | 28.00 | 64.03 | 44% |
| Returns for 5 years | 4.45 | 68.23 | 7% |
| Returns for 10 years | 57.17 | 271.03 | 21% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSRRX | 9.09 | N/A | N/A |
| Fidelity Strategic Real Return | |||
| FSAEX | 14.08 | N/A | N/A |
| Fidelity Series All-Sector Equity | |||
| FBONX | 38.41 | -0.17 | -0.44% |
| American Funds American Balanced 529-F-3 | |||
| PJHRX | 31.86 | -0.19 | -0.59% |
| PGIM Jennison Health Sciences R | |||
| DEYCX | 11.65 | -0.08 | -0.68% |
| BNY Mellon Large Cap Equity C | |||